Pharmaceutical company Aurobindo Pharma is set to release its first-quarter earnings today. The analysts are expecting a good set of numbers from the company this time. The stock is up 110 percent this year and in terms of valuations, it is trading at 15 times FY22 EPS.
The Street is expecting a revenue growth of 9.5 percent and EBITDA growth of 6 percent. Margins are expected to expand by 70 basis points (bps) to come in at 21.1 percent. Profit is expected to grow by 15 percent to come in at Rs 730 crore.
CNBC-TV18’s Sonal Bhutra lists out key expectations